🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Innovist raises Rs 136 Cr led by ICICI Venture; Accel exits

EntrackrEntrackr · 3m ago
Innovist raises Rs 136 Cr led by ICICI Venture; Accel exits
Medial

Innovist, the parent company of Bare Anatomy, has raised Rs 136 crore (approximately $16 million) in a Series B funding round led by ICICI Venture. The round saw participation from Mirabilis Investment Trust, Niveshaay Investment, and existing backer Sauce. The funding round includes both primary and secondary components and will be directed toward product development, business growth, and team expansion, the company said in a media release. In the round, the company provided exit to Accel, which came in via their seed program (atoms). Rohit Chawla, founder and CEO, said that Innovist is one of the fastest-growing BPC (beauty and personal care) firms in the country and aims to cross Rs 300 crore in revenue by FY25. While the company has not yet filed its annual statements for FY24, it reported operational revenue of Rs 36.53 crore in FY23, along with a loss of Rs 16.87 crore. Innovist, previously known as Onesto Labs, was founded in 2018 by Chawla, Sifat Khurana, and Vimal Bhola. The company provides personal care products and currently manages three brands: Bare Anatomy, Chemist at Play, and Sunscoop. To date, Innovist has raised over $26 million, including a $7 million Series A round led by the Amazon Smbhav Venture Fund. According to startup data platform TheKredible, prior to this round, Sauce.VC was the largest external stakeholder, followed by 72 Ventures, Accel India, and the Amazon Smbhav Fund. It competes with D2C beauty brands like Minimalist, Mamaearth, Wow Skin Science, and Sugar Cosmetics.

Deeptech startup Acculi Labs raises $1.5 Mn

EntrackrEntrackr · 11m ago
Deeptech startup Acculi Labs raises $1.5 Mn
Medial

Acculi Labs, a deep-tech life growth solution provider, has raised $1.5 million in a new investment round at a valuation of $25 million led by Sabi Holding India Ltd. The Bengaluru-based company had earlier raised Rs 5 crore in a seed funding round led by PirE Ventures back in 2020. The fresh fund will be utilized to accelerate the development of its conscious AI insights systems, enhance its manpower, operational efficiency, infrastructure development, Acculi Labs said in a press-release. Co-founded in May 2017 by Rupam Das and Hari Prasath M, Acculi Labs aims to make home-based care available to the patients. The company’s flagship product, Lyfas, enables easy and regular early diagnostics and monitoring for early-stage asymptomatic patients and helps them to approach their doctor at an early stage. According to Acculi Labs, it expanded offerings from an initial cardiac health assessment system to a comprehensive suite of health solutions with the launch of Lyfas.The platform claims that its mobile application is capable of non-invasively capturing psychophysiological biomarkers and delivering a detailed health report within three minutes. The company has developed Lyra, a cutting-edge, conscious AI that bridges the gap between carbon and silicon life forms. It has also launched Lyfas Udyam initiative, which provides a micro entrepreneurial circular economy for small entrepreneurs to start and run their businesses, leveraging the ecosystem, processes, and finance.

Risa Labs raises $3.5 Mn in seed round led by Binny Bansal

EntrackrEntrackr · 3m ago
Risa Labs raises $3.5 Mn in seed round led by Binny Bansal
Medial

Risa Labs has raised $3.5 million in a seed funding round led by Flipkart co-founder Binny Bansal, with participation from Oncology Ventures, General Catalyst, and others. The proceeds will be used to deploy its AI-based automation platform across 100 cancer centers in the US over the next two years. Co-founded in 2024 by Kshitij Jaggi and Kumar Shivang, Risa Labs offers a workflow orchestration platform called BOSS (Business Operating System as a Service). BOSS uses a network of AI agents, including large language models and digital twins, to automate administrative processes by breaking down complex workflows into micro tasks, addressing the problem of delays in life-saving treatments due to manual and error-prone workflows. Risa Labs claims that BOSS has already been deployed at a cancer center in the US, where it reduced prior authorisation times from 30 minutes to under five, processed over $1 million in medications, and cut administrative costs by two-thirds.

Download the medial app to read full posts, comements and news.